Pharmacoepidemiology, Health services research, Mental health, Substance use disorders, Child and adolescents health
Dr. Greta Bushnell received her PhD and an MSPH in Epidemiology, with a focus in pharmacoepidemiology, from the University of North Carolina at Chapel Hill Gillings School of Global Public Health. Prior to joining Rutgers, she completed a postdoctoral research fellowship in psychiatric epidemiology at Columbia University Mailman School of Public Health.
Dr. Greta Bushnell is a pharmacoepidemiologist focused on studying the use, effectiveness, and safety of pharmaceuticals. Broadly, Dr. Bushnell’s research focuses in the areas of psychiatric and pediatric pharmacoepidemiology and aims to improve treatment and outcomes in young people with mental illnesses and substance use disorders through informing clinical treatment decisions, policy, and interventions. Much of her research leverages large health care claims databases and applies epidemiological methods to address pertinent drug utilization and safety questions in children. Her most recent research has focused on the use and safety of benzodiazepines in youth. Dr. Bushnell’s research has been supported by the National Institute of Mental Health.
Social Media & Websites
Pubmed bibliography: https://www.ncbi.nlm.nih.gov/myncbi/greta.bushnell.1/bibliography/public/